bioRxiv Science⌕ Search

Biology subjects

Guo, G. L.

Publications and source records attributed to Guo, G. L..

2 recordsLinked to original sources

Intestinal stearoyl-CoA desaturase-1 regulates energy balance via alterations in bile acid homeostasis

Background and AimsStearoyl-CoA desaturase-1 (SCD1) converts saturated fatty acids into monounsaturated fatty acids and plays an important regulatory role in lipid metabolism. Previous studies have demonstrated that mice deficient in SCD1 are protected from diet-induced obesity and hepatic steatosis due to altered lipid esterification and increased energy expenditure. Previous studies in our lab have shown that intestinal SCD1 modulates intestinal and plasma lipids and alters cholesterol metabolism. Here we investigated a novel role for intestinal SCD1 in the regulation of systemic energy balance. MethodsTo interrogate the role of intestinal SCD1 in modulating whole body metabolism, intestine-specific Scd1 knockout (iKO) mice were maintained on standard chow diet or challenged with a high-fat diet (HFD). Studies included analyses of bile acid content and composition, metabolic phenotyping including body composition, indirect calorimetry, glucose tolerance analyses, and assessment of bile acid signaling pathways. ResultsiKO mice displayed elevated plasma and hepatic bile acid content and decreased fecal bile acid excretion, associated with increased expression of the ileal bile acid uptake transporter, Asbt. These increases were associated with increased expression of TGR5 targets, including Dio2 in brown adipose tissue and elevated plasma glucagon-like peptide-1 levels. Upon HFD challenge, iKO mice had reduced metabolic efficiency apparent through decreased weight gain despite higher food intake. Concomitantly, energy expenditure was increased, and glucose tolerance was improved in HFD-fed iKO mice. ConclusionOur results indicate that deletion of intestinal SCD1 has significant impacts on bile acid metabolism and whole-body energy balance, likely via activation of TGR5.

molecular biology↗

Bile Acid Regulates the Colonization and Dissemination of Candida albicans from the Gastrointestinal Tract by Controlling Host Defense System and Microbiota

Candida albicans (CA), a commensal and opportunistic eukaryotic organism, frequently inhabits the gastrointestinal (GI) tract and causes life-threatening infections. Antibiotic-induced gut dysbiosis is a major risk factor for increased CA colonization and dissemination from the GI tract. We identified a significant increase of taurocholic acid (TCA), a major bile acid in antibiotic-treated mice susceptible to CA infection. In vivo findings indicate that administration of TCA through drinking water is sufficient to induce colonization and dissemination of CA in wild type and immunosuppressed mice. Treatment with TCA significantly reduced mRNA expression of immune genes ang4 and Cxcr3 in the colon. In addition, TCA significantly decreased the relative abundance of three culturable species of commensal bacteria, Turicibacter sanguinis, Lactobacillus johnsonii, and Clostridium celatum, in both cecal contents and mucosal scrapings from colon. Taken together, our results indicate that TCA promotes fungal colonization and dissemination of CA from the GI tract by controlling host defense system and intestinal microbiota that play a critical role in regulating CA in the intestine. ImportanceBroad-spectrum antibiotics, FDA-approved bile acid drugs, and probiotics used to control metabolic and infectious diseases profoundly alter the level of TCA in the gut. Furthermore, TCA level is highly altered in a subset of cancer, colitis and surgery patients who are highly susceptible to CA infection. Inadvertently, these therapies and disease conditions could be either promoting CA colonization and dissemination. Our findings indicate that TCA alone can induce fungal colonization and dissemination from the intestine. Results from this study will have a significant impact in understanding how bile acids interact with the microbiota and host in regulating invasive fungal infections that originate from the intestine and to develop potential new antifungal therapeutics.

microbiology↗